Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 21, 2023. (Total: 58828 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 210 Records)

Next

Query Trace: Endometrial Cancer[original query]>>Original Studies[Product Type]
A deep learning model for lymph node metastasis prediction based on digital histopathological images of primary endometrial cancer.
Min Feng et al. Quantitative imaging in medicine and surgery 2023 13(3) 1899-1913
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.
Vanda Salutari et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023
Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
Aline Talhouk et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2023
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
Francesca Tavano et al. Molecular medicine (Cambridge, Mass.) 2023 29(1) 14
CXCR3 predicts the prognosis of endometrial adenocarcinoma.
He Dong et al. BMC medical genomics 2023 16(1) 20
Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing.
Cummings Shelly et al. JCO precision oncology 2023 7e2200415
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.
Vrede Stephanie W et al. JAMA network open 2022 5(12) e2247372
Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial Carcinoma
A Raffone et al, J Per Med, December 18, 2022
Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach.
Passero Lauren et al. BMC health services research 2022 22(1) 1411
Lessons learnt from the implementation of a colorectal cancer screening programme for lynch syndrome in a tertiary public hospital.
Dueñas Nuria et al. Cancer epidemiology 2022 82102291
Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry.
Noei Teymoordash Somayyeh et al. Caspian journal of internal medicine 2022 13(4) 772-779
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.
Thompson Emily F et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022
Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
Kurzrock Razelle et al. Cancers 2022 14(17)
Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.
Wen Kuo-Chang et al. Cancers 2022 14(17)
Prediction of Endometrial Cancer Recurrence by Using a Novel Machine Learning Algorithm: An Israeli Gynecologic Oncology Group study.
Houri Ohad et al. Journal of gynecology obstetrics and human reproduction 2022 102466
External validation study of endometrial cancer preoperative risk stratification model (ENDORISK).
Vinklerová Petra et al. Frontiers in oncology 2022 12939226
Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR Assay.
Phelps Rachel et al. Cancers 2022 14(15)
Microsatellite instability and oncological outcomes in Thai patients with endometrial cancer.
Atjimakul Thiti et al. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2022 1-7
Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test.
Kim Yoo-Na et al. Cancers 2022 14(14)
Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
Levine Monica D et al. Gynecologic oncology 2022
Heterogeneity in the psychosocial and behavioral responses associated with a diagnosis of suspected Lynch syndrome in women with endometrial cancer.
Jonnagadla Sowmya et al. Hereditary cancer in clinical practice 2022 20(1) 27
Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women.
Bafligil Cemsel et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.
Kurnit Katherine C et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022
Utility of germline multi-gene panel testing in patients with endometrial cancer.
Karpel Hannah C et al. Gynecologic oncology 2022
Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study.
Tsuruta Tomohiko et al. Japanese journal of clinical oncology 2022
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method.
Perrone Emanuele et al. Gynecologic oncology 2022
Evaluation and Monitoring of Endometrial Cancer Based on Magnetic Resonance Imaging Features of Deep Learning.
Tao Jingxiong et al. Contrast media & molecular imaging 2022 20225198592
MRI radiomics: A machine learning approach for the risk stratification of endometrial cancer patients.
Mainenti Pier Paolo et al. European journal of radiology 2022 149110226
Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer.
Choi Jungyoon et al. JCO precision oncology 2022 6e2100401
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
Schrijver Lieske H et al. Journal of the National Cancer Institute 2022
TOP